{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:57:23Z","timestamp":1761163043906,"version":"build-2065373602"},"reference-count":23,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T00:00:00Z","timestamp":1326672000000},"content-version":"vor","delay-in-days":2359,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:p>A 39\u2010year\u2010old man with schizophrenia developed severe catatonia, hyperthermia, muscle rigidity, tachycardia, leukocytosis, and elevated muscle enzyme levels while receiving zotepine therapy. Neuroleptic malignant syndrome (NMS) was diagnosed. After withdrawal of zotepine therapy, transfer to a neurologic intensive care unit, provision of supportive care, and administration of adjunctive bromocriptine therapy, the patient's fever and catatonia subsided. Biochemical irregularities spontaneously returned to normal with no complications. Antipsychotic therapy was restarted with risperidone 12 days after the patient's NMS resolved. After more than 1 year of follow\u2010up, he experienced no adverse events. A recent decrease in mortality from NMS is related to increased awareness of this disorder, but not to treatment with specific agents. Clinicians need to recognize NMS early; although rare, it is a potentially fatal complication of antipsychotic treatment.<\/jats:p>","DOI":"10.1592\/phco.2005.25.8.1156","type":"journal-article","created":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T04:47:51Z","timestamp":1128919671000},"page":"1156-1159","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Zotepine\u2010Induced Catatonia as a Precursor in the Progression to Neuroleptic Malignant Syndrome"],"prefix":"10.1002","volume":"25","author":[{"given":"Jui\u2010Hsiu","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinchen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju\u2010Yu","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng\u2010Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming\u2010Jen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,16]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92669-6"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770200085010"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.2190\/LXD2-JTXJ-3LPQ-9PDN"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30278-4"},{"key":"e_1_2_1_6_2","first-page":"18","article-title":"Mortality from neuroleptic malignant syndrome","volume":"50","author":"Shalev A","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198610000-00002"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(85)90060-5"},{"volume-title":"The neuroleptic malignant syndrome and related conditions","year":"1989","author":"Lazarus A","key":"e_1_2_1_9_2"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.11.1003.34528"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/57.3.238"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199809020-00006"},{"key":"e_1_2_1_13_2","first-page":"77","article-title":"Hypothermia caused by antipsychotic drugs in a schizophrenic patient","volume":"48","author":"Noto T","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(03)00332-4"},{"key":"e_1_2_1_15_2","first-page":"739","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association.","year":"1994"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199510000-00010"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1971.tb09935.x"},{"key":"e_1_2_1_18_2","first-page":"276","article-title":"Modification du taux de serotonine c\u00e9r\u00e9brale chez rat par les trifluoromethylphenyl\u20102\u2010ethyl aminopropane (fenfluramine 768S) [in French]","volume":"170","author":"Duhault J","year":"1967","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.32.405"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.6.811.32179"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(03)00036-9"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808802200606"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.3.271"},{"key":"e_1_2_1_24_2","first-page":"295","article-title":"Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients","volume":"50","author":"Rosebusk PI","year":"1989","journal-title":"J Clin Psychiatry"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.2005.25.8.1156","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.2005.25.8.1156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:15:00Z","timestamp":1761066900000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.2005.25.8.1156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1592\/phco.2005.25.8.1156"],"URL":"https:\/\/doi.org\/10.1592\/phco.2005.25.8.1156","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"2012-01-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}